Key result
First large animal model investigates substernal EV ICD system infections.
Why the study?
The extravascular implantable cardioverter-defibrillator with substernal lead implantation may offer advantages over transvenous and subcutaneous systems, but substernal infection had not been examined.
Does system explantation combined with antibiotics improve the resolution of EV ICD-related substernal infections compared to antibiotics alone in a large animal model?
Does system explantation combined with antibiotics improve the resolution of EV ICD-related substernal infections compared to antibiotics alone in a large animal model?
In a large animal model, EV ICD-related substernal infections were localized and treatable with system removal and antibiotic therapy, without progressing to bloodstream or sternal bone infections.
Answers are grounded in this paper and cite their sources.
Supports feasibility of explantation plus antibiotics for localized EV ICD infections; leaves open clinical translation from this animal model.
The extravascular implantable cardioverter-defibrillator (EV ICD) with lead implantation in the substernal space may provide clinical advantages over transvenous and subcutaneous systems. This is the first reported examination of substernal infection in large animals implanted with the EV ICD system.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2023) studied this question. Substernal extravascular implantable cardioverter-defibrillator (EV ICD) system infections were examined for the first time in a large animal model.
Synapse has enriched 10 related papers. Consider them for comparative context: